1. Human cord blood (hCB)-CD34+ humanized mice fail to reject human acute myeloid leukemia cells.
- Author
-
Tanaskovic, Olga, Verga Falzacappa, Maria Vittoria, and Pelicci, Pier Giuseppe
- Subjects
- *
CORD blood , *ACUTE myeloid leukemia , *BONE marrow , *MICE , *BONE marrow transplantation , *IMMUNE system - Abstract
Since their appearance, humanized mice carrying human immune system seemed promising tools to study the crosstalk between cancer and immunity. The NOD-scidIL2Rgammanull (NSG) mice engrafted with human cord blood (hCB)-CD34+ cells have been proposed to be a valuable tool to reproduce human immune system in mouse. However, the lack of solid evidences on the functionality of their human immune components limits their usage in immune-oncology. We report that (hCB)-CD34+ cells lose their ability to propagate and originate bone marrow-derived human immune cells after two serial transplantations in NSG mice. We demonstrate that transplants of bone marrow patient-derived acute myeloid leukemias (hAMLs) grow very similarly in the humanized (hCB)-CD34+ NSG and parental NSG mice. The similar extent of engraftment and development of leukemias in (hCB)-CD34+ NSG and controls suggests a poor human immune response against not compatible hAMLs. Our findings suggest that (hCB)-CD34+ NSG mice are transient and/or incomplete carriers of the human immune system and, therefore, represent a suboptimal tool to study the interaction between tumor and immune cells. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF